Coronavirus Disease 2019 (COVID-19) Real World Data Infrastructure: A Big-Data Resource for Study of the Impact of COVID-19 in Patient Populations With Immunocompromising Conditions
The successful development of the CRWDi enables researchers to address unanswered questions that have arisen during the COVID-19 pandemic. By making the data broadly and freely available to academic researchers, this real-world data system represents an important complement to existing consortia and clinical trials that have emerged during the healthcare crisis and is readily reproducible for future purposing.
Authors
- James M. Crawford (ORCID: https://orcid.org/0000-0002-8581-1093)
- Harvey W. Kaufman (ORCID: https://orcid.org/0000-0003-2850-9047)
- Yonah Ziemba (ORCID: https://orcid.org/0000-0002-9308-2695)
- Laura Gillim
- Cheryl B. Schleicher
- Shannon L. Reynolds (ORCID: https://orcid.org/0000-0003-1488-6044)
- Keri N. Althoff (ORCID: https://orcid.org/0000-0002-5068-6595)
- William A. Meyer (ORCID: https://orcid.org/0000-0003-2791-995X)
- Jeremy L. Warner (ORCID: https://orcid.org/0000-0002-2851-7242)
- Suki Subbiah (ORCID: https://orcid.org/0000-0002-1192-0879)
- Lynne Penberthy (ORCID: https://orcid.org/0000-0001-9372-9869)
- David Liew (ORCID: https://orcid.org/0000-0001-8451-8883)
- Oren J. Cohen (ORCID: https://orcid.org/0000-0002-6835-3473)
- Magdalene M. Assimon
- Lígia A. Pinto (ORCID: https://orcid.org/0000-0002-3130-9882)
- Suhyeon Yoon
- David Kwasny
- Catherine Theruviparampil
- Tracy L. Hammonds
- Zachary S Wallace
- Shilpa Kapur
Institutions
- Boston University (US)
- National Institutes of Health (US)
- Johns Hopkins University (US)
- Brown University (US)
- Rhode Island Hospital (US)
- Massachusetts General Hospital (US)
- Aetion (United States) (US)
- Frederick National Laboratory for Cancer Research (US)
- National Institute of Allergy and Infectious Diseases (US)
- National Cancer Institute (US)
- Quest Diagnostics (United States) (US)
- Louisiana State University Health Sciences Center New Orleans (US)
Publication Details
- Journal
- Open Forum Infectious Diseases
- Published
- 2024-12-23
- DOI
- https://doi.org/10.1093/ofid/ofaf021
- Citations
- 3
- Primary Topic
- COVID-19 and healthcare impacts
- Type
- article
- Field-Weighted Citation Impact
- 0.85
Funders
- U.S. Department of Health and Human Services
- American Society of Nephrology
- Bristol-Myers Squibb
- Sanofi
- Medpace
- BioCryst
- Quest Diagnostics
- Shionogi
- National Institutes of Health
- Centers for Disease Control and Prevention
- National Cancer Institute